Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.

Health Diagnostics

Health Care

Biotechnology

Personalis

Christopher Hall

Ken Brunt

Yuker Wang

Dr. Twinkal Marfatia

Dan Norton

Stephen Fairclough

Deepshikha Bhandari

Gail Stanley

Aaron Tachibana

Stephen Moore

Stephane Mouradian

Richard Chen

James Azzaro

The Scientific and Medical Team at Personalis is responsible for leading the research and development efforts in population sequencing and cancer genomics. They ensure the quality and efficiency of laboratory operations, manage the collection and analysis of comprehensive molecular data, and provide scientific and medical insights to support the development of next-generation cancer therapies. This team also oversees technical operations, scientific program management, and the integration of genomic data with clinical applications, ensuring compliance with GxP, CLIA’88, and CAP standards.

Scientific and Medical Team

Biopharma Business Development

Bioinformatics and Software Engineering Team

Scientific and Medical Team

About

Team members

Other teams at Personalis

Biopharma Business Development

Bioinformatics and Software Engineering Team